Загрузка...
Glioblastoma—a moving target
The slow development of effective treatment of glioblastoma is contrasted by the rapidly advancing research on the molecular mechanisms underlying the disease. Amplification and overexpression of receptor tyrosine kinases, particularly EGFR and PDGFRA, are complemented by mutations in the PI3K, RB1,...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Informa Healthcare
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3339557/ https://ncbi.nlm.nih.gov/pubmed/22512247 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/03009734.2012.676574 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|